Limited-disease small-cell lung cancer

Seminars in Surgical Oncology

Volumn 21, Issue 3, 2003, Pages 156-163

  Zimmermann, Frank B ^a   Bamberg, Michael ^b   Molls, Michael ^a   Jeremic, Branislav ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Chemotherapy; Limited disease; Radiotherapy; SCLC; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; IRINOTECAN; PACLITAXEL; TAXANE DERIVATIVE; TOPOTECAN; VINCRISTINE;

BLOOD TOXICITY; BRAIN RADIATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC VALUE; DIARRHEA; FUTUROLOGY; HISTOPATHOLOGY; HUMAN; INCIDENCE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; NEUTROPENIA; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DOSE FRACTIONATION; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS;

EID: 0141988820     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.10033     Document Type: Review

References (66)

1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics 2000. CA Cancer J Clin 200;50:7-33.
2. Zakowski MF: Pathology of small cell carcinoma of the lung. Semin Oncol 2003;30:3-8.
3. Mulshine JL, Treston AM, Brown HP, et al: Initiators and promoters of lung cancer. Chest 1993;103 Suppl 1:4S-11S.
4. Ihde DC, Pass HI, Glatstein EJ: Small cell lung cancer. In DeVita V, Hellman S, Rosenberg S (eds): Cancer-principles and practice of oncology. Philadelphia: J.B. Lipincott Co.; 1993. p. 723-758.
5. Curran WJ: Combined-modality therapy for limited-stage small cell lung cancer. Semin Oncol 2001;28:14-22.
6. Green RA, Humphrey E, Close H, Patno ME: Alkylating agents in bronchogenic carcinoma. Am J Med 1969;46:516-525.
7. Stahel RA, Ginsberg R, Havemann K: Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989;5:119-126.
8. Cohen MH, Ihde DC, Bunn Jr PA, et al: Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep 1979;62:163-170.
9. Warde P, Payne D: Does thoracic radiation improve survival and local control in limited-stage small cell carcinoma of the lung? J Clin Oncol 1992;10:890-895.
10. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-1627.
11. Auperin A, Arriagada R, Pignon JP, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-484.
12. Sandler AB: Chemotherapy for small cell lung cancer. Semin Oncol 2003;30:9-25.
13. Einhorn LH, Crawford J, Birch R, et al: Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer. J Clin Oncol 1988;6:451-456.
14. Fukuoka M, Furuse K, Saijo N, et al: Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 1991;83:855-861.
15. Turrisi AT, Kim K, Blum R, et al: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:264-271.
16. Takada M, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group study 9104. J Clin Oncol 2002;20:3054-3060.
17. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S: Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small cell lung cancer. J Clin Oncol 1997;15:893-900.
18. Kosmidis P, Samantas E, Fountzilas G, et al: Cisplatin/etoposide vs carboplatin/etoposide and irradiation in small-cell lung cancer: a randomized phase III study. Semin Oncol 1994;21(Suppl 6): 23-30.
19. Maurer LH, Tulloh M, Weiss R, et al: A randomized combined modality trial on small cell carcinoma of the lung. Cancer 1980;45:30-39.
20. Woods RL, Levi JA: Chemotherapy for small cell lung cancer (SCLC): a randomised study of maintenance therapy with caclophosphamide, adriamycin and vincristine (CAV) after remission induction with cis-platinum (CIS-DDP), VP 16-213 and radiotherapy. Proc Am Soc Clin Oncol 1984;3:214.
21. Cullen M, Morgan D, Gregory W, et al: Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother Pharmacol 1986;17:157-160.
22. Bleehen NM, Fayers PM, Girling DJ, Stephens RJ: Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Br J Cancer 1989;59:584-590.
23. Lebeau B, Chastang CL, Allard P, et al: Six vs. twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomised clinical trial. Eur Respir J 1992;5:286-290.
24. Giaccone G, Dalesio O, McVie GJ, et al: Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. J Clin Oncol 1993;11:1230-1240.
25. Beith JM, Clarke SJ, Woods RL, et al: Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung. Eur J Cancer 1996;32A: 438-443.
26. Sculier JP, Paesmans M, Bureau G, et al: Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. J Clin Oncol 1996;14:2337-2344.
27. Byrne MJ, Van Hazel G, Trotter J, et al: Maintenance chemotherapy in limited small cell lung cancer: a randomised controlled clinical trial. Br J Cancer 1989;59:584-590.
28. Spiro SG, Souhami RL, Geddes DM, et al: Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer 1989;59:578-583.
29. Johnson DH, Kim K, Sause W: Cispaltin (p) & etoposide (e) + thoracic radiotherapy (TRT) administered once or twice daily (bid) in limited stage (LS) small cell lung caner (SCLC): final report of Intergroup trial 0096. Proc Am Soc Clin Oncol 1996;15:374.
30. Goldie JG, Coldman AJ: The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res 1984;44:3643-3653.
31. Cohen MH, Broder LE, Fossieck BE, et al: Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 1977;61:349-354.
32. Mehta C, Vogl SE, Farber S: High-dose cyclophosphamide (C) in the induction (IND) chemotherapy (CT) of small cell lung cancer (SCLC)-minor improvements in rate of remission and survival. Proc Am Assoc Cancer Res 1982;23:165.
33. Figueredo AT, Hryniuk WM, Strautmanis I, et al: Cotrimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer. J Clin Oncol 1985;3:54-64.
34. Arriagada R, Le Chevalier T, Pignon JP, et al: Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993;25:1848-1852.
35. Steward WP, von Pawel J, Gatzemaier U, et al: Effects of granulocyte colony-stimulating factor and dose-intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomised study of 300 patients. J Clin Oncol 1998;16:642-650.
36. Thatcher N, Girling DJ, Howood P, et al: Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council multicenter randomised trial. J Clin Oncol 2000;18:395-404.
37. Noda K, Nishiwaki Y, Kawahara M, et al: The Japan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85-91.
38. Schiller JH, Adak S, Cella D, et al: Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2001;19:2114-2122.
39. Mavroudis D, Papadakis E, Veslemes M, et al: A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer. Ann Oncol 2001;12:463-470.
40. Niell HB, Herndon JE, Miller AA: Randomized phase III intergroup trial (CALGB 9732) of etoposide and cisplatin with or without paclitaxel and G-CSF in patients with extensive stage small cell lung cancer. Proc Am Soc Clin Oncol 2002;21:293a.
41. Gatzmeier U, von Pawel J, Macha H: A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate, and vincristive (CEV) in previously untreated small cell lung cancer [Abstract]. Proc Am Soc Clin Oncol 2000;19:483.
42. Birch R, Greco F, Hainsworth J: Preliminary results of a randomized study comparing etoposide and carboplatin with or without paclitaxel in newly diagnosed small cell lung cancer [Abstract]. Proc Am Soc Clin Oncol 2000;19:490.
43. Levitan N, Dowlati A, Shina D, et al: Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma. J Clin Oncol 2000;18:1102-1109.
44. Bremnes RM, Sundstrom S, Vilsik J, Aasebo U: Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small cell lung cancer. J Clin Oncol 2001;19:3532-3538.
45. Ettinger DS, Seiferhals WF, Abrams RA: Cisplatin, etoposide, paclitaxel, and concurrent hyperfractionated thoracic radiotherapy for patients with limited disease small cell lung cancer: preliminary results of RTOG 96009. Proc Am Soc Clin Oncol 2000;19:490a.
46. Sandler A, Declerck L, Wagner H: A phase II study of cisplatin plus etoposide plus paclitaxel and concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): an Eastern Cooperative Oncology Group trial. Proc Am Soc Clin Oncol 2000;19:491a.
47. Perry MC, Eaton WL, Propert KJ, et al: Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-918.
48. Schultz HP, Nielsen OS, Sell A: Timing of chest radiation with respect to combination chemotherapy in small cell lung cancer, limited disease [Abstract]. Lung Cancer 1988;4:153.
49. Work E, Nielsen O, Bentzen S, et al: Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small cell lung cancer. J Clin Oncol 1997;15:3030-3037.
50. Murray N, Coy P, Pater J, et al: Importance of timing for thoracic irradiation in the combined modailty treatment of limited stage small cell lung cancer. J Clin Oncol 1993;11:336-344.
51. Goldie JG, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-1735.
52. Choi NC, Carey RR: Importance of radiation dose in achieving improved locoregional tumor control in small-cell lung carcinoma: an update. Int J Radiat Oncol Biol Phys 1989;17:307-310.
53. Papac RJ, Son Y, Bien R, et al: Improved local control of thoracic disease in small-cell lung cancer with higher dose thoracic irradiation and cyclic chemotherapy. Int J Radiat Oncol Biol Phys 1987;13:993-998.
54. Choi N, Herndon J, Rosenman J, et al: Phase I study to determine the maximum tolerated dose of radiation I standard daily and accelerated twice daily radiotherapy schedules with concurrent chemotherapy for limited stage small cell lung cancer: CALGB 8837. J Clin Oncol 1998;16:3528-3536.
55. Bonner JA, Sloan JA, Shanahan TG, et al: Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol 1999;17:2681-2681.
56. Kies MS, Mira JG, Crowley JJ, et al: Multimodal therapy for limited small cell lung cancer. A randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with widefield versus reduced volume radiation in partial responders: a Southwest Oncology Group study. J Clin Oncol 1987;5:592-600.
57. Perez CA, Krauss S, Bartolucci AA, et al: Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: a randomized prospective study by the Southeastern Cancer Study Group. Cancer 1981;47:2407-2413.
58. White JE, Chen T, McCracken J, et al: The influence of radiation therapy quality control on survival, response, and sites in oat cell carcinoma of the lung. Preliminary report of a Southwest Oncology Group study. Cancer 1982;50:1084-1090.
59. Rosen ST, Makuch RW, Lichter AS, et al: Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer: potential benefit restricted to patients with complete response. Am J Med 1983;74:615-624.
60. Nugent JL, Bunn PA, Matthews M, et al: CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing patterns with lengthening survival. Cancer 1979;44:1885-1898.
61. Pederson AG, Kristjansen PEG, Hansen HH: Prophylactic cranial irradiation and small cell lung cancer. Cancer Treat Rev 1988;15:85-103.
62. Arriagada R, LeChevalier T, Borie F, et al: Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183-190.
63. Gregor A, Cull A, Stephens RJ, et al: Prophylactic cranial irradiation is indicated following complete response to induction chemotherapy in small cell lung cancer: results of a multicenter randomized trial. Eur J Cancer 1997;33:1752-1758.
64. Laplanche A, Monnet I, Santos-Miranda JA, et al: Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Lung Cancer 1998;21:193-201.
65. Gregor A: Prophylactic cranial irradiation in small-cell lung cancer: is it ever indicated? Oncology (Huntingt) 1998;12 (Suppl 2):19-24.
66. Rosenman J, Choi NC: Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain. Int J Radiat Oncol Biol Phys 1982;8:1041-1043.